{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T04:38:25Z","timestamp":1792730305475,"version":"4.5.0"},"reference-count":73,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2027,1,1]],"date-time":"2027-01-01T00:00:00Z","timestamp":1798761600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2027,1,1]],"date-time":"2027-01-01T00:00:00Z","timestamp":1798761600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,9,12]],"date-time":"2026-09-12T00:00:00Z","timestamp":1789171200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Experimental Neurology"],"published-print":{"date-parts":[[2027,1]]},"DOI":"10.1016\/j.expneurol.2026.116022","type":"journal-article","created":{"date-parts":[[2026,9,11]],"date-time":"2026-09-11T23:18:43Z","timestamp":1789168723000},"page":"116022","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Midbrain organoids as next-generation models for Parkinson's disease: From pathogenesis to therapeutic discovery"],"prefix":"10.1016","volume":"407","author":[{"given":"Dai-yi","family":"Jiang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shun-yu","family":"Yao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miao-qiao","family":"Du","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lan-xin","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xu-hui","family":"Kang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8390-7668","authenticated-orcid":false,"given":"Yong","family":"Peng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.expneurol.2026.116022_bb0005","article-title":"Protocol for the differentiation of human embryonic stem cells into midbrain dopaminergic neurons","volume":"4","author":"Bader","year":"2023","journal-title":"STAR Protoc."},{"issue":"5","key":"10.1016\/j.expneurol.2026.116022_bb0010","first-page":"1567","article-title":"Graft-induced dyskinesias in cell therapy for Parkinson\u2019s disease: lessons from past trials and implications for organoid-derived grafts","volume":"147","author":"Barker","year":"2024","journal-title":"Brain"},{"key":"10.1016\/j.expneurol.2026.116022_bb0015","doi-asserted-by":"crossref","first-page":"1561","DOI":"10.1038\/s42003-024-07273-4","article-title":"Modeling early phenotypes of Parkinson\u2019s disease by age-induced midbrain-striatum assembloids","volume":"7","author":"Barmpa","year":"2024","journal-title":"Commun. Biol."},{"issue":"1","key":"10.1016\/j.expneurol.2026.116022_bb0020","article-title":"Investigating the ageing-Parkinson\u2019s disease nexus: standardisation of in vitro models and techniques by the PD-AGE network","volume":"11","author":"Bury","year":"2025","journal-title":"NPJ Parkinson\u2019s Dis."},{"key":"10.1016\/j.expneurol.2026.116022_bb0025","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-026-74355-8","article-title":"iSCORE-PD: an isogenic stem cell collection to research Parkinson's disease","volume":"17","author":"Busquets","year":"2026","journal-title":"Nat. Commun."},{"issue":"5","key":"10.1016\/j.expneurol.2026.116022_bb0030","doi-asserted-by":"crossref","first-page":"824","DOI":"10.1016\/j.stem.2025.02.010","article-title":"Vascular network-inspired diffusible scaffolds for engineering functional midbrain organoids","volume":"32","author":"Cai","year":"2025","journal-title":"Cell Stem Cell"},{"issue":"3","key":"10.1016\/j.expneurol.2026.116022_bb0035","first-page":"456","article-title":"Vascularized human brain organoids with blood-brain barrier properties for modeling neurodegeneration","volume":"21","author":"Cakir","year":"2024","journal-title":"Nat. Methods"},{"key":"10.1016\/j.expneurol.2026.116022_bb0040","doi-asserted-by":"crossref","DOI":"10.1007\/s12264-026-01669-4","article-title":"Optimized midbrain organoid transplantation restores dopaminergic nigrostriatal pathway and motor function in Parkinson\u2019s disease mouse model","author":"Chen","year":"2026","journal-title":"Neurosci. Bull."},{"issue":"11","key":"10.1016\/j.expneurol.2026.116022_bb0045","first-page":"1567","article-title":"Deep learning-based phenotypic screening of Parkinson\u2019s disease organoids identifies novel neuroprotective compounds","volume":"31","author":"Choi","year":"2024","journal-title":"Cell Stem Cell"},{"issue":"1","key":"10.1016\/j.expneurol.2026.116022_bb0050","doi-asserted-by":"crossref","DOI":"10.1186\/s13287-021-02326-5","article-title":"Towards physiologically relevant human pluripotent stem cell (hPSC) models of Parkinson's disease","volume":"12","author":"Coccia","year":"2021","journal-title":"Stem Cell Res. Ther."},{"key":"10.1016\/j.expneurol.2026.116022_bb0055","doi-asserted-by":"crossref","DOI":"10.3389\/fbioe.2022.1081145","article-title":"Customizable 3D printed perfusion bioreactor for the engineering of stem cell microenvironments","volume":"10","author":"Dupard","year":"2023","journal-title":"Front. Bioeng. Biotechnol."},{"issue":"5","key":"10.1016\/j.expneurol.2026.116022_bb0060","doi-asserted-by":"crossref","DOI":"10.1128\/AAC.00440-20","article-title":"Tilorone, a broad-spectrum antiviral for emerging viruses","volume":"64","author":"Ekins","year":"2020","journal-title":"Antimicrob. Agents Chemother."},{"issue":"1","key":"10.1016\/j.expneurol.2026.116022_bb0065","doi-asserted-by":"crossref","DOI":"10.1186\/s13287-025-04660-4","article-title":"Three-dimensional midbrain organoids: a next-generation tool for Parkinson's disease modelling and drug discovery","volume":"16","author":"Elvira","year":"2025","journal-title":"Stem Cell Res. Ther."},{"issue":"15","key":"10.1016\/j.expneurol.2026.116022_bb0070","doi-asserted-by":"crossref","first-page":"4181","DOI":"10.1038\/s44318-025-00494-1","article-title":"Advances, challenges, and opportunities of human midbrain organoids for modelling of the dopaminergic system","volume":"44","author":"Fiorenzano","year":"2025","journal-title":"EMBO J."},{"issue":"3","key":"10.1016\/j.expneurol.2026.116022_bb0075","first-page":"289","article-title":"Long-term outcomes of fetal tissue transplantation in Parkinson\u2019s disease: implications for iPSC-derived cell therapies","volume":"81","author":"Freed","year":"2024","journal-title":"JAMA Neurol."},{"issue":"17","key":"10.1016\/j.expneurol.2026.116022_bb0080","article-title":"A cell therapy approach based on iPSC-derived midbrain organoids for the restoration of motor function in a Parkinson\u2019s disease mouse model","volume":"10","author":"Fu","year":"2024","journal-title":"Heliyon"},{"issue":"3","key":"10.1016\/j.expneurol.2026.116022_bb0085","first-page":"567","article-title":"T cell-mediated neurotoxicity in human midbrain organoids: modeling adaptive immune contributions to Parkinson\u2019s disease","volume":"28","author":"Gerasimova","year":"2025","journal-title":"Nat. Neurosci."},{"issue":"20","key":"10.1016\/j.expneurol.2026.116022_bb0090","doi-asserted-by":"crossref","DOI":"10.1002\/advs.202409040","article-title":"\u03b1-Synuclein pathology spreads in a midbrain-hindbrain assembloid model","volume":"12","author":"Gomez-Giro","year":"2025","journal-title":"Adv. Sci."},{"issue":"8","key":"10.1016\/j.expneurol.2026.116022_bb0095","first-page":"2134","article-title":"Engineering perfusable blood vessels in human brain organoids using microfluidic systems","volume":"24","author":"Ham","year":"2024","journal-title":"Lab Chip"},{"issue":"1","key":"10.1016\/j.expneurol.2026.116022_bb0100","first-page":"45","article-title":"Standardized reporting guidelines for brain organoid experiments (STROBE-org): a community-driven initiative","volume":"28","author":"International Brain Organoid Consortium","year":"2025","journal-title":"Nat. Neurosci."},{"issue":"25","key":"10.1016\/j.expneurol.2026.116022_bb0105","article-title":"On-chip neural induction boosts neural stem cell commitment: toward a pipeline for iPSC-based therapies","volume":"11","author":"Jain","year":"2024","journal-title":"Adv. Sci. (Weinh) or Adv Sci (Weinh)."},{"issue":"2","key":"10.1016\/j.expneurol.2026.116022_bb0110","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1016\/j.stem.2016.07.005","article-title":"Midbrain-like organoids from human pluripotent stem cells contain functional dopaminergic and neuromelanin-producing neurons","volume":"19","author":"Jo","year":"2016","journal-title":"Cell Stem Cell"},{"key":"10.1016\/j.expneurol.2026.116022_bb0115","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1016\/j.omtm.2023.08.008","article-title":"Necessity of strengthening the current clinical regulatory for companion diagnostics: an institutional comparison of the FDA, EMA, and MFDS","volume":"30","author":"Kang","year":"2023","journal-title":"Mol. Ther. - Methods Clin. Dev."},{"issue":"1","key":"10.1016\/j.expneurol.2026.116022_bb0120","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1186\/s11658-025-00765-z","article-title":"NT2-derived astrocyte-neuron co-culture reflects physiological relevance and offers research validity","volume":"30","author":"Kedracka-Krok","year":"2025","journal-title":"Cell. Mol. Biol. Lett."},{"issue":"6","key":"10.1016\/j.expneurol.2026.116022_bb0125","first-page":"913","article-title":"LRRK2 G2019S mutation alters dopaminergic differentiation via NR2F1","volume":"24","author":"Kim","year":"2019","journal-title":"Cell Stem Cell"},{"key":"10.1016\/j.expneurol.2026.116022_bb0130","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1016\/j.stem.2023.05.015","article-title":"Advanced human iPSC-based preclinical model for Parkinson\u2019s disease with optogenetic alpha-synuclein aggregation","volume":"30","author":"Kim","year":"2023","journal-title":"Cell Stem Cell"},{"issue":"15","key":"10.1016\/j.expneurol.2026.116022_bb0135","article-title":"3D bioprinting of vascularized human midbrain organoids for scalable drug screening","volume":"36","author":"Kim","year":"2024","journal-title":"Adv. Mater."},{"key":"10.1016\/j.expneurol.2026.116022_bb0140","doi-asserted-by":"crossref","first-page":"1275","DOI":"10.1016\/j.tibtech.2024.11.021","article-title":"Vascularized human brain organoids: current possibilities and future directions","volume":"43","author":"Kistemaker","year":"2025","journal-title":"Trends Biotechnol."},{"issue":"18","key":"10.1016\/j.expneurol.2026.116022_bb0145","first-page":"4567","article-title":"Reproducibility crisis in brain organoid research: causes, consequences, and solutions","volume":"187","author":"Knoblich","year":"2024","journal-title":"Cell"},{"issue":"2","key":"10.1016\/j.expneurol.2026.116022_bb0150","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/j.stem.2017.07.001","article-title":"A little bit of guidance: Mini brains on their route to adolescence","volume":"21","author":"Koch","year":"2017","journal-title":"Cell Stem Cell"},{"key":"10.1016\/j.expneurol.2026.116022_bb0155","series-title":"Parkinson's Disease: Pathogenesis and Clinical Aspects","article-title":"Parkinson's Disease: Etiology, Neuropathology, and Pathogenesis","author":"Kouli","year":"2018"},{"key":"10.1016\/j.expneurol.2026.116022_bb0160","article-title":"Alpha-synuclein pathology is associated with astrocyte senescence in a midbrain organoid model of familial Parkinson\u2019s disease","volume":"128","author":"Kr\u00fcger","year":"2024","journal-title":"Mol. Cell. Neurosci."},{"issue":"3","key":"10.1016\/j.expneurol.2026.116022_bb0165","article-title":"Generation of functional human midbrain organoids with accelerated maturity for modeling Parkinson\u2019s disease","volume":"19","author":"Kwak","year":"2024","journal-title":"Stem Cell Reports"},{"key":"10.1016\/j.expneurol.2026.116022_bb0170","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejphar.2024.176819","article-title":"Experimental models of Parkinson's disease: challenges and opportunities","volume":"980","author":"Lal","year":"2024","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.expneurol.2026.116022_bb0175","doi-asserted-by":"crossref","first-page":"2329","DOI":"10.1038\/nprot.2014.158","article-title":"Generation of cerebral organoids from human pluripotent stem cells","volume":"9","author":"Lancaster","year":"2014","journal-title":"Nat. Protoc."},{"key":"10.1016\/j.expneurol.2026.116022_bb0180","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1038\/nature12517","article-title":"Cerebral organoids model human brain development and microcephaly","volume":"501","author":"Lancaster","year":"2013","journal-title":"Nature"},{"issue":"1","key":"10.1016\/j.expneurol.2026.116022_bb0185","doi-asserted-by":"crossref","DOI":"10.1186\/s13195-025-01926-0","article-title":"Single-cell analysis reveals shared and distinct molecular signatures in brain organoid models of neurodegeneration and neuroinflammation","volume":"18","author":"Le Bars","year":"2025","journal-title":"Alzheimer's Res. Ther."},{"issue":"1","key":"10.1016\/j.expneurol.2026.116022_bb0190","doi-asserted-by":"crossref","DOI":"10.1186\/s13045-026-01805-7","article-title":"Nanotechnology-enhanced CAR-T therapy strategies in cancer, aging, and autoimmune diseases","volume":"19","author":"Li","year":"2026","journal-title":"J. Hematol. Oncol."},{"key":"10.1016\/j.expneurol.2026.116022_bb0195","first-page":"3794","article-title":"Human midbrain organoids from SNCA triplication iPSCs recapitulate key features of synucleinopathy","volume":"143","author":"Mohamed","year":"2020","journal-title":"Brain"},{"key":"10.1016\/j.expneurol.2026.116022_bb0200","doi-asserted-by":"crossref","first-page":"1144","DOI":"10.1016\/j.stemcr.2017.03.010","article-title":"Derivation of human midbrain-specific organoids from neuroepithelial stem cells","volume":"8","author":"Monzel","year":"2017","journal-title":"Stem Cell Rep."},{"key":"10.1016\/j.expneurol.2026.116022_bb0205","first-page":"145","article-title":"Machine learning prediction of drug efficacy in Parkinson\u2019s disease using multi-modal organoid data","volume":"10","author":"M\u00fcller","year":"2024","journal-title":"NPJ Parkinsons Dis."},{"key":"10.1016\/j.expneurol.2026.116022_bb0210","doi-asserted-by":"crossref","DOI":"10.1016\/j.mcn.2024.103919","article-title":"Alpha-synuclein pathology is associated with astrocyte senescence in a midbrain organoid model of familial Parkinson\u2019s disease","volume":"128","author":"Muwanigwa","year":"2024","journal-title":"Mol. Cell. Neurosci."},{"issue":"1","key":"10.1016\/j.expneurol.2026.116022_bb0215","doi-asserted-by":"crossref","DOI":"10.1186\/s13041-025-01268-w","article-title":"Human midbrain organoids reveal the characteristics of axonal mitochondria specific to dopaminergic neurons","volume":"19","author":"Nishijima","year":"2025","journal-title":"Mol. Brain"},{"issue":"3","key":"10.1016\/j.expneurol.2026.116022_bb0220","first-page":"567","article-title":"Organoid-on-chip platforms for real-time monitoring of Parkinson\u2019s disease pathophysiology","volume":"25","author":"Park","year":"2025","journal-title":"Lab Chip"},{"issue":"6","key":"10.1016\/j.expneurol.2026.116022_bb0225","first-page":"1023","article-title":"A consensus framework for quality assessment of human brain organoids","volume":"21","author":"Pasca","year":"2024","journal-title":"Nat. Methods"},{"key":"10.1016\/j.expneurol.2026.116022_bb0230","doi-asserted-by":"crossref","DOI":"10.1016\/j.expneurol.2025.115287","article-title":"Gene-modified animal models of Parkinson\u2019s disease","volume":"390","author":"Peng","year":"2025","journal-title":"Exp. Neurol."},{"issue":"8","key":"10.1016\/j.expneurol.2026.116022_bb0235","first-page":"1234","article-title":"Cross-laboratory comparison of human brain organoid differentiation protocols reveals protocol-dependent variability and proposes standardization guidelines","volume":"42","author":"Quadrato","year":"2024","journal-title":"Nat. Biotechnol."},{"issue":"5","key":"10.1016\/j.expneurol.2026.116022_bb0240","article-title":"Fully automated high-throughput workflow for midbrain organoid generation and analysis","volume":"1","author":"Renner","year":"2021","journal-title":"Cell Rep. Methods"},{"key":"10.1016\/j.expneurol.2026.116022_bb0245","doi-asserted-by":"crossref","first-page":"1803","DOI":"10.1038\/s41592-023-02080-x","article-title":"In vitro modeling of the human dopaminergic system using spatially arranged ventral midbrain\u2013striatum\u2013cortex assembloids","volume":"20","author":"Reumann","year":"2023","journal-title":"Nat. Methods"},{"key":"10.1016\/j.expneurol.2026.116022_bb0250","doi-asserted-by":"crossref","DOI":"10.1038\/s41531-023-00616-8","article-title":"Impaired neuron differentiation in GBA-associated Parkinson\u2019s disease is linked to cell cycle defects in organoids","volume":"9","author":"Rosety","year":"2023","journal-title":"NPJ Parkinsons Dis."},{"key":"10.1016\/j.expneurol.2026.116022_bb0255","first-page":"1836","article-title":"Microglia integration into human midbrain organoids accelerates synaptic maturation","volume":"29","author":"Sabat\u00e9-Soler","year":"2022","journal-title":"Cell Stem Cell"},{"key":"10.1016\/j.expneurol.2026.116022_bb0260","doi-asserted-by":"crossref","DOI":"10.1016\/j.exphem.2024.104669","article-title":"Inducible pluripotent stem cell models to study bone marrow failure and MDS predisposition syndromes","volume":"143","author":"Sahoo","year":"2025","journal-title":"Exp. Hematol."},{"key":"10.1016\/j.expneurol.2026.116022_bb0265","article-title":"Stereo-seq reveals spatial architecture of human midbrain organoids and dopaminergic neuron subtype organization","volume":"15","author":"Shi","year":"2024","journal-title":"Nat. Commun."},{"issue":"3","key":"10.1016\/j.expneurol.2026.116022_bb0270","doi-asserted-by":"crossref","first-page":"964","DOI":"10.1093\/brain\/awab446","article-title":"Single-cell sequencing of human midbrain reveals glial activation and a Parkinson-specific neuronal state","volume":"145","author":"Smaji\u0107","year":"2022","journal-title":"Brain J. Neurol."},{"issue":"25","key":"10.1016\/j.expneurol.2026.116022_bb0275","doi-asserted-by":"crossref","DOI":"10.1002\/advs.202508815","article-title":"Microglia mitochondria support neuronal maturation via metabolic and transcriptional reprogramming in human 3D in vitro brain model","volume":"13","author":"Sterben","year":"2026","journal-title":"Adv. Sci."},{"issue":"7","key":"10.1016\/j.expneurol.2026.116022_bb0280","article-title":"Clinical translation of iPSC-derived dopaminergic neurons for Parkinson\u2019s disease: lessons from Japan\u2019s regulatory pathway","volume":"19","author":"Takahashi","year":"2024","journal-title":"Stem Cell Rep."},{"key":"10.1016\/j.expneurol.2026.116022_bb0285","doi-asserted-by":"crossref","DOI":"10.1016\/j.parkreldis.2025.107833","article-title":"Allogenic transplantation therapy of iPS cell-derived dopamine progenitors for Parkinson's disease -current status of the Kyoto trial and future perspectives","volume":"135","author":"Takahashi","year":"2025","journal-title":"Parkinsonism Relat. Disord."},{"issue":"44","key":"10.1016\/j.expneurol.2026.116022_bb0290","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.adu7944","article-title":"BrainSTEM: a single-cell multiresolution fetal brain atlas reveals transcriptomic fidelity of human midbrain cultures","volume":"11","author":"Toh","year":"2025","journal-title":"Sci. Adv."},{"issue":"8","key":"10.1016\/j.expneurol.2026.116022_bb0295","first-page":"2045","article-title":"Spatial transcriptomics of human brain organoids reveals patterned gene expression across developmental axes","volume":"187","author":"Trevino","year":"2024","journal-title":"Cell"},{"issue":"3","key":"10.1016\/j.expneurol.2026.116022_bb0300","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2021.109864","article-title":"The Parkinson's-disease-associated mutation LRRK2-G2019S alters dopaminergic differentiation dynamics via NR2F1","volume":"37","author":"Walter","year":"2021","journal-title":"Cell Rep."},{"issue":"2","key":"10.1016\/j.expneurol.2026.116022_bb0305","first-page":"234","article-title":"Artificial intelligence-driven drug discovery using human midbrain organoids: from image analysis to therapeutic prediction","volume":"9","author":"Wang","year":"2025","journal-title":"Nat. Biomed. Eng."},{"key":"10.1016\/j.expneurol.2026.116022_bb0310","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.abb1540","article-title":"Neurodevelopmental defects and neurodegenerative phenotypes in human brain organoids carrying Parkinson\u2019s disease-linked DNAJC6 mutations","volume":"7","author":"Wulansari","year":"2021","journal-title":"Sci. Adv."},{"issue":"2","key":"10.1016\/j.expneurol.2026.116022_bb0315","doi-asserted-by":"crossref","DOI":"10.1016\/j.isci.2026.114674","article-title":"Single-cell transcriptomics revealed molecular vulnerability in a human midbrain-like organoid model of Parkinson's disease","volume":"29","author":"Xie","year":"2026","journal-title":"iScience"},{"key":"10.1016\/j.expneurol.2026.116022_bb0320","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1016\/j.ajhg.2021.12.009","article-title":"Midbrain organoids mimic early embryonic neurodevelopment and recapitulate LRRK2-p.Gly2019Ser-associated gene expression","volume":"109","author":"Zagare","year":"2022","journal-title":"Am. J. Hum. Genet."},{"issue":"1","key":"10.1016\/j.expneurol.2026.116022_bb0325","first-page":"36","article-title":"MIRO1 mutation leads to metabolic maladaptation resulting in Parkinson\u2019s disease-associated dopaminergic neuron loss","volume":"11","author":"Zagare","year":"2025","journal-title":"NPJ Parkinson\u2019s Dis."},{"issue":"4","key":"10.1016\/j.expneurol.2026.116022_bb0330","doi-asserted-by":"crossref","DOI":"10.1016\/j.drudis.2026.104742","article-title":"Brain organoids in Parkinson\u2019s disease drug development: human-specific models for translational discovery","volume":"31","author":"Zagare","year":"2026","journal-title":"Drug Discov. Today"},{"issue":"5","key":"10.1016\/j.expneurol.2026.116022_bb0335","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1016\/j.neuron.2013.05.029","article-title":"Rapid single-step induction of functional neurons from human pluripotent stem cells","volume":"78","author":"Zhang","year":"2013","journal-title":"Neuron"},{"issue":"12","key":"10.1016\/j.expneurol.2026.116022_bb0340","doi-asserted-by":"crossref","DOI":"10.3390\/biomedicines10123026","article-title":"How well do rodent models of Parkinson\u2019s disease recapitulate early non-motor phenotypes? A systematic review","volume":"10","author":"Zhang","year":"2022","journal-title":"Biomedicines"},{"issue":"1","key":"10.1016\/j.expneurol.2026.116022_bb0345","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1038\/s41380-022-01892-1","article-title":"Microglia-containing human brain organoids for the study of brain development and pathology","volume":"28","author":"Zhang","year":"2023","journal-title":"Mol. Psychiatry"},{"issue":"1","key":"10.1016\/j.expneurol.2026.116022_bb0350","article-title":"Tilorone mitigates the propagation of \u03b1-synucleinopathy in a midbrain-like organoid model","volume":"22","author":"Zhang","year":"2024","journal-title":"J. Transl. Med."},{"key":"10.1016\/j.expneurol.2026.116022_bb0355","article-title":"Integrating spatial transcriptomics with proteomics to map Lewy body-like pathology in Parkinson\u2019s disease organoids","author":"Zhang","year":"2025","journal-title":"bioRxiv"},{"key":"10.1016\/j.expneurol.2026.116022_bb0360","doi-asserted-by":"crossref","first-page":"2673","DOI":"10.7150\/thno.80271","article-title":"Human iPSC-derived midbrain organoids functionally integrate into striatum circuits and restore motor function in a mouse model of Parkinson\u2019s disease","volume":"13","author":"Zheng","year":"2023","journal-title":"Theranostics"},{"key":"10.1016\/j.expneurol.2026.116022_bb0365","doi-asserted-by":"crossref","DOI":"10.3389\/fnins.2026.1764964","article-title":"Brain organoids as precision models for neurodegenerative diseases: from disease modeling to drug discovery","volume":"20","author":"Zheng","year":"2026","journal-title":"Front. Neurosci."}],"container-title":["Experimental Neurology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014488626003894?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014488626003894?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T04:07:18Z","timestamp":1792728438000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0014488626003894"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2027,1]]},"references-count":73,"alternative-id":["S0014488626003894"],"URL":"https:\/\/doi.org\/10.1016\/j.expneurol.2026.116022","relation":{},"ISSN":["0014-4886"],"issn-type":[{"value":"0014-4886","type":"print"}],"subject":[],"published":{"date-parts":[[2027,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Midbrain organoids as next-generation models for Parkinson's disease: From pathogenesis to therapeutic discovery","name":"articletitle","label":"Article Title"},{"value":"Experimental Neurology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.expneurol.2026.116022","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"116022"}}